Research & Education

Screening for Lung Cancer - What Clinicians Need to Know

September 6, 2017 at 9:00PM EDT

The National Lung Screening Trial provided clear evidence of a lung cancer mortality reduction in high-risk patients who undergo screening with low-dose CT.

Management of Squamous Cell Carcinoma of the Lung

Wednesday August 16, 2017, at 9:00PM EDT

This one hour webinar focuses on squamous cell carcinoma of the lung.

Proton Therapy for Lung Cancer

Tuesday, August 8, 2017, at 9:00PM EDT

This one hour webinar will explore the use of proton therapy for lung cancer.

Management of Immunotherapy Side Effects

Tuesday, August 1, 2017, at 7:00 PM CEST (Central European Summer Time)

In recent years checkpoint inhibitors, particularly PD-1/PD-L1 inhibitors, have become an important component of the management of advanced NSCLC patients.

PD-L1 Assessment and Biomarkers for Immunotherapy

Wednesday, July 12, 2017, at 7:00PM CEST - Recording Available

This one-hour webinar will address PD-L1 assessment as a biomarker for immunotherapy.

Advances in the Treatment of Lung Cancer: ASCO 2017 Update

Wednesday, July 12, 2017, at 9:00 PM EDT - Recording Available

This live session of IASLC Lung Cancer Grand Rounds features Dr. Karen Kelly.

Biology and Treatment of Thoracic Neuroendocrine Tumors

Wednesday, June 21, 2017 at 9:00PM EDT - Recording Available

This live session of IASLC Lung Cancer Grand Rounds features Dr. Gregory Riely. In this program Dr. Riely will review recent advances in our understanding of the biology and treatment of thoracic neuroendocrine tumors.

Adjuvant Therapy of Lung Cancer: New Perspectives

Tuesday, June 20, 2017 at 7:00PM CEST (Central European Summer Time) - Recording Available

Dr. Scagliotti and Dr. Van Houtte explore adjuvant therapy of lung cancer in this one-hour webinar.

Immunotherapy: A New Standard of Care in NSCLC

Monday, May 15, 2017 - 6:00PM CEST (Central European Summer Time) - Recording Available

Cancer immunotherapy is emerging as one of the most promising areas of cancer research and treatment.Overall, the goal of cancer immunotherapy is to stimulate a patient's immune system to recognize cancer cells as foreign and attack them.

Locally Advanced NSCLC: Where Are We, Where Do We Go From Here?

Tuesday, May 9, 2017 at 9:00PM EDT - Recording Available

This webinar will provide an updated overview of current standard therapies for stage III NSCLC. It will also review the most recent data and current trials likely to impact standards of care.

Pages